These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 32840378)
1. Alkamides and Piperamides as Potential Antivirals against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Gutierrez-Villagomez JM; Campos-García T; Molina-Torres J; López MG; Vázquez-Martínez J J Phys Chem Lett; 2020 Oct; 11(19):8008-8016. PubMed ID: 32840378 [TBL] [Abstract][Full Text] [Related]
2. Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery. Sternberg A; McKee DL; Naujokat C Curr Top Med Chem; 2020; 20(16):1423-1433. PubMed ID: 32416679 [TBL] [Abstract][Full Text] [Related]
3. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection. Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306 [TBL] [Abstract][Full Text] [Related]
6. In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking. Joshi T; Joshi T; Sharma P; Mathpal S; Pundir H; Bhatt V; Chandra S Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4529-4536. PubMed ID: 32373991 [TBL] [Abstract][Full Text] [Related]
7. Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19. Choudhary S; Silakari O Virus Res; 2020 Nov; 289():198146. PubMed ID: 32866534 [TBL] [Abstract][Full Text] [Related]
8. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19. Vardhan S; Sahoo SK Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628 [TBL] [Abstract][Full Text] [Related]
9. In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection. Martorana A; Gentile C; Lauria A Viruses; 2020 Jul; 12(8):. PubMed ID: 32722574 [TBL] [Abstract][Full Text] [Related]
10. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM Life Sci; 2020 Aug; 255():117831. PubMed ID: 32450166 [TBL] [Abstract][Full Text] [Related]
11. Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study. Gentile D; Patamia V; Scala A; Sciortino MT; Piperno A; Rescifina A Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32340389 [TBL] [Abstract][Full Text] [Related]
12. Using serpins cysteine protease cross-specificity to possibly trap SARS-CoV-2 Mpro with reactive center loop chimera. Jairajpuri MA; Ansari S Clin Sci (Lond); 2020 Sep; 134(17):2235-2241. PubMed ID: 32869854 [TBL] [Abstract][Full Text] [Related]
13. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy. Goyal B; Goyal D ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186 [TBL] [Abstract][Full Text] [Related]
14. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Froggatt HM; Heaton BE; Heaton NS J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534 [TBL] [Abstract][Full Text] [Related]
15. Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study. Hosseini FS; Amanlou M Life Sci; 2020 Oct; 258():118205. PubMed ID: 32777300 [TBL] [Abstract][Full Text] [Related]
16. Quantum chemical insight into molecular structure, NBO analysis of the hydrogen-bonded interactions, spectroscopic (FT-IR, FT-Raman), drug likeness and molecular docking of the novel anti COVID-19 molecule 2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]-N-(4-fluorophenyl)acetamide - dimer. Mary SJJ; Siddique MUM; Pradhan S; Jayaprakash V; James C Spectrochim Acta A Mol Biomol Spectrosc; 2021 Jan; 244():118825. PubMed ID: 32866803 [TBL] [Abstract][Full Text] [Related]
18. Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors. Jiménez-Alberto A; Ribas-Aparicio RM; Aparicio-Ozores G; Castelán-Vega JA Comput Biol Chem; 2020 Oct; 88():107325. PubMed ID: 32623357 [TBL] [Abstract][Full Text] [Related]
19. Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA. Bello M; Martínez-Muñoz A; Balbuena-Rebolledo I J Mol Model; 2020 Nov; 26(12):340. PubMed ID: 33184722 [TBL] [Abstract][Full Text] [Related]
20. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease. Akaji K; Konno H Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]